比较多参数MRI与混合多维MRI诊断临床显著前列腺癌的放射科医师表现
本回顾性分析纳入61例经前列腺切除或MRI融合经直肠超声活检确诊前列腺癌的男性,比较4名放射科医师使用多参数MRI与混合多维MRI诊断临床显著前列腺癌的表现、观察者间一致性与判读时间。混合多维MRI在部分医师中AUC更高、特异度更高、观察者间一致性更高且判读时间更短。
要点
- 混合多维MRI观察者间一致性高于多参数MRI(Cronbach α=0.88 vs 0.26)。
- 混合多维MRI平均判读时间短于多参数MRI(73秒 vs 254秒)。
- 第4名医师混合多维MRI的AUC高于多参数MRI(0.64 vs 0.46,P=.04)。
核心结论
- 放射科医师使用混合多维MRI诊断临床显著前列腺癌的表现为相似或改善,观察者间一致性更高,判读时间更短。
研究设计与样本
- 回顾性分析,纳入2012年8月至2020年2月间经前列腺切除或MRI融合经直肠超声活检确诊前列腺癌的男性61例(平均年龄61岁±8)。
- 每例均行多参数MRI(三平面T2加权、扩散加权和动态对比增强成像)和混合多维MRI(多回波时间与b值组合)。
- 由4名具有1-20年经验的放射科医师独立判读多参数MRI和混合多维MRI,两次判读间隔4周洗脱期,记录PI-RADS评分、病灶位置和判读时间。
- 采用bootstrap分析比较每名医师的多参数MRI与混合多维MRI判读时间、观察者间一致性(Cronbach α)和受试者工作特征曲线下面积(AUC)表现。
诊断标准与关键数值
- 每例患者AUC:第1-4名医师多参数MRI为0.61、0.71、0.59、0.64,混合多维MRI为0.66、0.60、0.50、0.46,P分别为.57、.20、.32、.04。
- 每例患者特异度:第1-4名医师多参数MRI为48%、78%、48%、46%,混合多维MRI为37%、26%、0%、7%,P分别为.34、<.001、<.001、<.001。
- 经验最少的第4名医师使用混合多维MRI诊断表现改善(AUC 0.64 vs 0.46,P=.04)。
- 观察者间一致性:混合多维MRI Cronbach α=0.88(95%CI:0.82,0.92),多参数MRI Cronbach α=0.26(95%CI:0.10,0.52),α>.60提示可靠性,P=.03。
- 判读时间:混合多维MRI平均73秒±43,多参数MRI平均254秒±133,P=.03。
临床应用与阅片要点
- 原文结论为放射科医师使用混合多维MRI诊断临床显著前列腺癌的表现为相似或改善,观察者间一致性更高,判读时间更短,未据此给出具体阅片流程推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Variability of acquisition and interpretation of prostate multiparametric MRI (mpMRI) persists despite implementation of the Prostate Imaging Reporting and Data System (PI-RADS) version 2.1 due to the range of reader experience and subjectivity of lesion characterization. A quantitative method, hybrid multidimensional MRI (HM-MRI), may introduce objectivity. Purpose To compare performance, interobserver agreement, and interpretation time of radiologists using mpMRI versus HM-MRI to diagnose clinically significant prostate cancer. Materials and Methods In this retrospective analysis, men with prostatectomy or MRI-fused transrectal US biopsy-confirmed prostate cancer underwent mpMRI (triplanar T2-weighted, diffusion-weighted, and dynamic contrast-enhanced imaging) and HM-MRI (with multiple echo times and b value combinations) from August 2012 to February 2020. Four readers with 1-20 years of experience interpreted mpMRI and HM-MRI examinations independently, with a 4-week washout period between interpretations. PI-RADS score, lesion location, and interpretation time were recorded. mpMRI and HM-MRI interpretation time, interobserver agreement (Cronbach alpha), and performance of area under the receiver operating characteristic curve (AUC) analysis were compared for each radiologist with use of bootstrap analysis. Results Sixty-one men (mean age, 61 years ± 8 [SD]) were evaluated. Per-patient AUC was higher for HM-MRI for reader 4 compared with mpMRI (AUCs for readers 1-4: 0.61, 0.71, 0.59, and 0.64 vs 0.66, 0.60, 0.50, and 0.46; P = .57, .20, .32, and .04, respectively). Per-patient specificity was higher for HM-MRI for readers 2-4 compared with mpMRI (specificity for readers 1-4: 48%, 78%, 48%, and 46% vs 37%, 26%, 0%, and 7%; P = .34, P < .001, P < .001, and P < .001, respectively). Diagnostic performance improved for the reader least experienced with HM-MRI, reader 4 (AUC, 0.64 vs 0.46; P = .04). HM-MRI interobserver agreement (Cronbach alpha = 0.88 [95% CI: 0.82, 0.92]) was higher than that of mpMRI (Cronbach alpha = 0.26 [95% CI: 0.10, 0.52]; α > .60 indicates reliability; P = .03). HM-MRI mean interpretation time (73 seconds ± 43 [SD]) was shorter than that of mpMRI (254 seconds ± 133; P = .03). Conclusion Radiologists had similar or improved diagnostic performance, higher interobserver agreement, and lower interpretation time for clinically significant prostate cancer with hybrid multidimensional MRI than multiparametric MRI. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Turkbey in this issue.
引用
- Lee, Chatterjee, Karademir, et al. Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer with Multiparametric versus Hybrid Multidimensional MRI. Radiology. 2022. PMID: 35880981. doi:10.1148/radiol.211895
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。